DR. DROPIN UK LIMITED

Company Registration Number:
14522983 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2025

Period of accounts

Start date: 01 January 2025

End date: 31 December 2025

DR. DROPIN UK LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2025

Balance sheet
Notes

DR. DROPIN UK LIMITED

Balance sheet

As at 31 December 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 227,131 303,322
Total fixed assets: 227,131 303,322
Current assets
Debtors: 4 219,764 79,388
Cash at bank and in hand: 85,499 73,635
Total current assets: 305,263 153,023
Creditors: amounts falling due within one year: 5 (243,417) (112,364)
Net current assets (liabilities): 61,846 40,659
Total assets less current liabilities: 288,977 343,981
Creditors: amounts falling due after more than one year: 6 (3,013,037) (1,967,434)
Total net assets (liabilities): (2,724,060) (1,623,453)
Capital and reserves
Called up share capital: 1 1
Profit and loss account: (2,724,061) (1,623,454)
Shareholders funds: (2,724,060) (1,623,453)

The notes form part of these financial statements

DR. DROPIN UK LIMITED

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 May 2026
and signed on behalf of the board by:

Name: Daniel Sorli
Status: Director

The notes form part of these financial statements

DR. DROPIN UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

DR. DROPIN UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

2. Employees

2025 2024
Average number of employees during the period 3 3

DR. DROPIN UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible Assets

Total
Cost £
At 01 January 2025 405,510
Additions 1,329
Disposals (2,227)
At 31 December 2025 404,612
Depreciation
At 01 January 2025 102,188
Charge for year 76,163
On disposals (870)
At 31 December 2025 177,481
Net book value
At 31 December 2025 227,131
At 31 December 2024 303,322

DR. DROPIN UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Debtors

2025 2024
££
Debtors due after more than one year: 0 0

DR. DROPIN UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

5. Creditors: amounts falling due within one year note

2025 2024 Net obligations under finance leases and hire purchase contracts 4,881 5,349 Trade creditors 152,106 92,169 Taxation 4,379 1,467 Other creditors 3,214 4,020 Accruals 78,837 9,359 Total 243,417 112,364

DR. DROPIN UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

6. Creditors: amounts falling due after more than one year note

Amounts owed to group undertakings 3,013,037 1,957,204 Other loans - 10,230 Total 3,013,037 1,967,434

DR. DROPIN UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

7. Financial commitments

The company had no material capital commitments at the financial year-ended 31 December 2025.

DR. DROPIN UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

8. Post balance sheet events

There have been no significant events affecting the company since the financial year-end.